Insider Transactions by Brumm Joshua T

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentMar 08, 2024Sale$15.74726,68611,434,554917,728Mar 12, 2024, 09:56 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentMar 11, 2024Sale$17.02116,3871,981,142604,385Mar 12, 2024, 09:56 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentMar 07, 2024Sale$25.859,086234,873554,385Mar 11, 2024, 09:57 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentFeb 29, 2024Sale$16.5211,040182,381568,991Mar 01, 2024, 09:38 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentMar 01, 2024Sale$17.29188,9603,267,138657,951Mar 01, 2024, 09:38 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentJan 03, 2024Sale$10.16102,3661,039,676636,154Jan 04, 2024, 09:49 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentJan 04, 2024Sale$11.84437,0725,173,050803,507Jan 04, 2024, 09:49 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksDec 11, 2023Sale$10.727,58581,311584,971Dec 12, 2023, 05:33 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksSep 18, 2023Sale$9.4112,032113,221233,679Sep 20, 2023, 04:47 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksSep 12, 2023Sale$10.417,67279,866245,711Sep 13, 2023, 07:50 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksJun 08, 2023Sale$9.2091,088837,681330,771Jun 12, 2023, 09:22 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksJun 09, 2023Sale$7.19153,1641,100,483346,353Jun 12, 2023, 09:22 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksJun 12, 2023Sale$7.08359,1082,544,003441,131Jun 12, 2023, 09:22 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksMar 14, 2023Sale$13.337,31897,549322,483Mar 15, 2023, 05:49 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksDec 12, 2022Sale$10.873,32236,110329,801Dec 13, 2022, 05:04 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksOct 07, 2022Sale$7.2028,400204,480218,823Oct 11, 2022, 09:00 AM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksOct 10, 2022Option Exercise$6.75391,6002,641,342400,423Oct 11, 2022, 09:00 AM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksSep 20, 2022Option Exercise$13.7011,836162,153204,623Sep 21, 2022, 04:07 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksSep 15, 2022Option Exercise$14.053,48048,894216,459Sep 15, 2022, 05:25 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksJul 06, 2022Option Exercise$8.2410,96390,335219,939Jul 06, 2022, 06:18 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksJun 14, 2022Option Exercise$4.953,54017,523206,784Jun 15, 2022, 08:02 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksMar 11, 2022Sale$8.733,38429,542210,324Mar 14, 2022, 05:07 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksSep 20, 2021Sale$15.613,42553,464103,602Sep 22, 2021, 08:02 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksSep 21, 2021Sale$16.114,58473,84899,018Sep 22, 2021, 08:02 PM
VSARVersartis, Inc.Brumm Joshua TCOO and CFOOct 19, 2017Sale$2.551,3263,381201,269Oct 23, 2017, 04:58 PM
VSARVersartis, Inc.Brumm Joshua TCOO and CFOJun 13, 2017Sale$16.051,42122,807105,595Jun 14, 2017, 06:50 PM
VSARVersartis, Inc.Brumm Joshua TCOO and CFOMay 16, 2017Sale$17.401,26321,976107,016May 17, 2017, 06:29 PM
VSARVersartis, Inc.Brumm Joshua TCOO and CFOFeb 24, 2017Option Exercise$11.7360,000703,963135,779Feb 28, 2017, 07:33 PM
VSARVersartis, Inc.Brumm Joshua TCOO and CFOJan 30, 2017Sale$13.852,94540,794105,779Jan 31, 2017, 08:36 PM
VSARVersartis, Inc.Brumm Joshua TChief Financial OfficerDec 27, 2016Sale$15.8599015,69264,824Dec 29, 2016, 06:15 PM
VSARVersartis, Inc.Brumm Joshua TChief Financial OfficerDec 07, 2016Sale$13.253,02140,02865,814Dec 08, 2016, 05:18 PM
VSARVersartis, Inc.Brumm Joshua TChief Financial OfficerJun 15, 2016Sale$10.631,44815,39258,835Jun 17, 2016, 04:06 PM
VSARVersartis, Inc.Brumm Joshua TChief Financial OfficerMay 20, 2016Sale$7.871,2659,95660,283May 20, 2016, 07:18 PM
VSARVersartis, Inc.Brumm Joshua TChief Financial OfficerDec 30, 2015Sale$12.4499012,31235,548Jan 04, 2016, 06:56 PM
VSARVersartis, Inc.Brumm Joshua TChief Financial OfficerNov 12, 2015Buy$9.992,50024,97536,538Nov 13, 2015, 05:37 PM
VSARVersartis, Inc.Brumm Joshua TChief Financial OfficerJun 11, 2015Option Exercise$18.512,59748,07835,413Jun 15, 2015, 06:02 PM